Switzerland
EU
DE
EN
Product Finder
watchlist
Best buy
Publications
Login
News
Products
Blockchain Report
Invest
Markets
Partners
News
Products
Blockchain Report
Invest
Markets
Partners
Product Finder
watchlist
Best buy
Publications
Login
DE
EN
Vifor Pharma AG
G2A
CHF 169.50
Facebook
Twitter
Linkedin
Xing
Mail
valor:
1553646
isin:
CH0364749348
Sector:
Health Care
Vifor Pharma AG
Price:
CHF 169.50
G2A
Share
Facebook
Twitter
Linkedin
Xing
Mail
valor:
1553646
isin:
CH0364749348
Sector:
Health Care
RIC
VIFNE.S
Bloomberg
VIFN SW EQUITY
Asset Class
Stock
Country
Switzerland
Reference Currency
CHF
Trading Exchange
SIX Swiss Exchange (SWX)
Trading Currency
CHF
Bid
168.75
25.05.2022
100.00
Ask
172.00
25.05.2022
150.00
Last
169.50
25.05.2022
Daily High
174.75
Change in %
-3.00 %
Change absolut
-1.80
Dividend Yield
1.75 %
Hist. volatility 30d
4'157.74 %
Hist. volatility 90d
3'053.86 %
Hist. volatility 180d
3'560.02 %
Overview Structured Products on Vifor Pharma AG
Leverage
Participation
Yield Enhancement
Capital Protection
with additional Credit Risk
{{u.cnt20}}
{{u.cnt13}}
{{u.cnt12}}
{{u.cnt11}}
{{u.cnt14}}
Exchange Traded Funds (ETFs)
{{etfs}}
Leverage
{{u.cnt20}}
Participation
{{u.cnt13}}
Yield Enhancement
{{u.cnt12}}
Capital Protection
{{u.cnt11}}
with additional Credit Risk
{{u.cnt14}}
Exchange Traded Funds (ETFs)
{{etfs}}
Trading Desk, 09/12/2019
«The Week»: +91.98% mit NJEABP Auf Partners Group
Trading Desk, 02/12/2019
«The Week»: +201.23% mit Mini-Future NKKABP auf Nasdaq 100 seit Juni 2019
Trading Desk, 11/11/2019
«The Week»: Bleiben Sie dabei
Details
RIC
VIFNE.S
Bloomberg
VIFN SW EQUITY
Asset Class
Stock
Country
Switzerland
Reference Currency
CHF
Quotes
Trading Exchange
SIX Swiss Exchange (SWX)
Trading Currency
CHF
Bid
168.75
25.05.2022
100.00
Ask
172.00
25.05.2022
150.00
Last
169.50
25.05.2022
Daily High
174.75
Change in %
-3.00 %
Change absolut
-1.80
Valuations
Dividend Yield
1.75 %
Hist. volatility 30d
4'157.74 %
Hist. volatility 90d
3'053.86 %
Hist. volatility 180d
3'560.02 %
Charts
Related Products
Overview Structured Products on Vifor Pharma AG
Leverage
Participation
Yield Enhancement
Capital Protection
with additional Credit Risk
{{u.cnt20}}
{{u.cnt13}}
{{u.cnt12}}
{{u.cnt11}}
{{u.cnt14}}
Exchange Traded Funds (ETFs)
{{etfs}}
Leverage
{{u.cnt20}}
Participation
{{u.cnt13}}
Yield Enhancement
{{u.cnt12}}
Capital Protection
{{u.cnt11}}
with additional Credit Risk
{{u.cnt14}}
Exchange Traded Funds (ETFs)
{{etfs}}
Posts
Trading Desk, 09/12/2019
«The Week»: +91.98% mit NJEABP Auf Partners Group
Trading Desk, 02/12/2019
«The Week»: +201.23% mit Mini-Future NKKABP auf Nasdaq 100 seit Juni 2019
Trading Desk, 11/11/2019
«The Week»: Bleiben Sie dabei
